U.S. Household Products Stock News

With tech and health care stocks under pressure and oil prices reacting to Middle East risk, investors are watching how large integrated energy companies respond to the latest swings in sentiment. This mix of equity pullback, higher crude prices and softer retail data has created fresh winners and laggards. This article examines three global oil producers that appear especially exposed to the current news backdrop. The stocks covered below are just a sample, and the full screen highlights 15...

ImmunityBio (IBRX) stock drew fresh attention after the company appointed Dr. Jim Yong Kim as Vice Chairman, reflecting a push to deepen global partnerships and support wider access to its immunotherapy programs. See our latest analysis for ImmunityBio. The appointment of Dr. Jim Yong Kim comes after a strong run in ImmunityBio’s share price, with a year to date share price return of 292.08% and a one year total shareholder return of 225.93%. Recent momentum has been steadier, with a 30 day...

MeiraGTx Holdings (MGTX) drew fresh attention after reporting second quarter and half year 2026 results, with revenue and earnings figures that marked a clear shift from prior period losses. See our latest analysis for MeiraGTx Holdings. The earnings swing has come alongside a sharp shift in sentiment toward MeiraGTx Holdings. The share price is at US$13.77, with a 90 day share price return of 50.82%, contributing to a 1 year total shareholder return of 72.77% and a 3 year total shareholder...

Kura Oncology (KURA) is back in focus after its second quarter 2026 earnings showed higher revenue alongside a wider net loss, arriving just days after new scientific data on its approved menin inhibitor ziftomenib. See our latest analysis for Kura Oncology. Kura Oncology’s recent scientific update on ziftomenib and the second quarter earnings release have come alongside strong momentum in the stock, with a 7 day share price return of 14.52% and a 1 year total shareholder return of 50.80%...

AvalonBay Communities (AVB) has been removed from several S&P indices, including the S&P 500 and S&P Global benchmarks. This index exclusion is an important development for investors who track liquidity and index related trading flows. See our latest analysis for AvalonBay Communities. At a share price of $184.06, AvalonBay Communities has seen its 30 day share price return fall 4.4%, while the year to date share price return is 2%. Over the longer term, total shareholder return has been...

Why Enovix Is Suddenly on Investors’ Radar Enovix (ENVX) is back in focus after CEO Raj Talluri resigned, with CFO Ryan Benton stepping in as interim CEO and executive chairman T.J. Rodgers taking a more active operating role. See our latest analysis for Enovix. The CEO change at Enovix comes after a steep reset in sentiment, with the share price down 54.44% year to date and the 1 year total shareholder return declining 64.65%. This signals fading momentum as investors reassess execution...

Why Taboola.com Stock Is Back On Investors’ Radar Taboola.com (TBLA) has drawn fresh attention after reporting second quarter 2026 results that moved from a net loss to net income, alongside new revenue guidance for the third quarter and full year. See our latest analysis for Taboola.com. Even with Taboola.com guiding to third quarter and full year revenue ranges and reporting a move to net income in the second quarter, the share price has fallen 26.33% over the past month and 23.27% over the...

In recent coverage, Happen Bank (NASDAQ: HAPN), formerly LendingClub, was highlighted for posting year-over-year earnings-per-share growth of 51.5% and generating materially higher net margins than rival SoFi in 2026. The analysis emphasized that Happen’s tighter lending discipline and stronger profitability metrics set it apart within fintech banking, particularly against less profitable peers. Next, we’ll examine how Happen’s robust earnings growth and margin strength reshape its...

Douglas Emmett (DEI) has drawn fresh attention after filing a US$175.35 million shelf registration for 15,000,000 common shares linked to an employee stock ownership plan, following recent guidance and earnings indicating ongoing losses. See our latest analysis for Douglas Emmett. At a share price of US$11.60, Douglas Emmett has had a mixed run, with the 30 day share price return down 7.27% while the year to date share price return is up 4.79%, and the 1 year total shareholder return down...

With the U.S. Iran ceasefire now expired and markets largely calm despite higher geopolitical risk, investors are staring at a mix of vulnerability and potential opportunity. Defense and military contractors in our Global Defense and Military Contractors screener sit close to this story, as governments reassess security priorities and budgets. This article walks through 3 stocks that appear positively exposed to the current news backdrop and explains what that could mean for your...

MGIC Investment (MTG) recently reported Q2 earnings with revenue roughly matching expectations and earnings per share above analyst estimates. Management highlighted a 14.5% return on equity, and the stock gained about 1.9% following the release. See our latest analysis for MGIC Investment. For context, MGIC Investment’s share price has a 90 day share price return of 19.33% and a year to date share price return of 6.72%, while the 1 year total shareholder return is 16.69% and the 5 year total...

In August 2026, Enact Holdings, Inc. reported second-quarter 2026 results showing revenue of US$317.31 million and net income of US$174.84 million, alongside basic and diluted earnings per share from continuing operations of US$1.25, all above the prior-year period. On the same day, the company reinforced its focus on capital returns by declaring a US$0.24 per-share dividend and completing a US$155.09 million buyback program that retired 3,684,091 shares, or 2.62% of its stock. We’ll now...

Multiple August announcements around MaxLinear (MXL) products for AI data centers and new client collaborations have put the stock back in focus. Investors are weighing how this broader portfolio could influence long term fundamentals. See our latest analysis for MaxLinear. The recent product launches for AI data centers and new client collaborations have arrived during a sharp move in MaxLinear’s share price, with a 7 day share price return of 23.85% and a year to date share price return of...

TechnipFMC plc recently announced it had secured a “significant” contract, valued between US$75 million and US$250 million, from Azule Energy to design and manufacture flexible flowlines, risers, and related equipment for the West Hub Tails extension of the Block 15/06 Agogo Integrated Development. This award, which will be booked into third-quarter 2026 inbound orders, highlights TechnipFMC’s role in consolidating West Hub production through the Agogo FPSO, reinforcing demand for its core...

In August 2026, Harrow, Inc. reported second-quarter revenue of US$70.66 million versus US$63.74 million a year earlier, swung to a net loss of US$17.27 million, and reiterated its 2026 revenue guidance of US$350 million to US$365 million. Just days earlier, Harrow agreed to acquire TYRVAYA nasal spray for up to US$100 million, aiming to broaden its dry eye disease franchise with a drop-free treatment that complements its existing VEVYE offering. Next, we’ll examine how reaffirmed 2026...

Agios Pharmaceuticals (AGIO) has drawn investor focus after recent trading left the stock at a last close of $33.63. With mixed return figures across different periods, the company’s rare disease portfolio is gaining fresh attention. See our latest analysis for Agios Pharmaceuticals. Over the past year, Agios Pharmaceuticals has combined a 23.73% year to date share price return with a 21.28% 90 day share price gain, yet the 1 year total shareholder return declined 10.20%. This suggests that...

Why Tarsus Pharmaceuticals stock is in focus after Q2 2026 Tarsus Pharmaceuticals (TARS) is back on investors radar after its Q2 2026 earnings report showed higher revenue, a smaller net loss, and a higher full year sales outlook for XDEMVY. See our latest analysis for Tarsus Pharmaceuticals. Tarsus Pharmaceuticals shares have reacted positively to the Q2 2026 update, with a 17.99% 1 month share price return and a 15.21% 3 month share price return, while the year to date share price is still...

With the clock ticking on potential 50% U.S. tariffs on Canadian goods, investors are watching domestic industrials in a new light. Companies with U.S. heavy operations and lower Canada revenue exposure could face a very different trade impact than cross border peers, for better or worse. This article walks through 3 stocks from that group and explains how the current tariff standoff might affect each one. The sample of stocks below is only a starting point, since the full screen surfaced 61...

Hamilton Lane’s August 4, 2026 report showed first‑quarter revenue of US$275.33 million and net income of US$80.46 million, with basic earnings per share from continuing operations of US$1.94, all higher than the same period a year earlier. At the same time, the company declared a quarterly dividend of US$0.60 per Class A share, lifting its full‑year dividend target by 11%, which underscores management’s confidence in current cash flows and capital‑return capacity. We’ll now examine how this...

Klaviyo, Inc. reported past second-quarter 2026 results with revenue of US$370.58 million and a narrower net loss of US$8.85 million, while also issuing higher full-year revenue guidance and confirming third-quarter expectations. The company is pairing this improved financial profile with AI-focused expansion, acquiring Agency’s team and technology and appointing founder Elias Torres as Chief Product Officer to accelerate its agent product line. We’ll now examine how Klaviyo’s raised...

Aura Minerals (AUGO) just reported quarterly and half year results that show higher sales and a sharp swing to profit, while also reaffirming its 2026 production targets to give investors clearer visibility. See our latest analysis for Aura Minerals. The strong earnings release, dividend declaration and recent buyback have come alongside a sharp move in Aura Minerals' stock, with a 30 day share price return of 56.39% and a one year total shareholder return of 188.55% signalling strong...

Oil is back in the spotlight as Brent edges toward US$90, inflation worries return and war with Iran keeps traders on alert about global supply. At the same time, higher US Treasury yields are pressuring valuations while strong earnings keep stocks near record highs. This article walks through 3 large energy producers that screens suggest are most exposed to this mix of rising crude, rates and profit expectations. The 3 stocks below are just a starting sample, and the full screen surfaced 8...

The Chefs' Warehouse, Inc. previously began a refinancing process, marketing and later upsizing a new US$675 million term loan facility to refinance existing debt, redeem convertible notes, fund capital expenditures, and support general corporate purposes. This prospective refinancing could meaningfully reshape the company’s capital structure by consolidating borrowings into a single term loan while potentially extending maturities and increasing financial flexibility. We’ll now examine how...

Hagerty (HGTY) is back in focus after its Broad Arrow unit reported record results at The Quail Auction, along with raised full year revenue and earnings guidance that contrasted with mixed second quarter figures. See our latest analysis for Hagerty. Hagerty shares trade at US$12.86 after a slight 1-day decline in the share price return of 0.85%, although a 16.38% 90-day share price return and a 46.30% three-year total shareholder return suggest momentum has been building over time. If this...